Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-17-001210
Filing Date
2017-06-30
Accepted
2017-06-29 17:58:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422cyt_06292017.htm SC 13G 207463
2 JOINT FILING AGREEMENT ex991to13g07422cyt_062917.htm EX-99.1 12715
  Complete submission text file 0001193805-17-001210.txt   221747
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89140 | Film No.: 17939739
SIC: 2834 Pharmaceutical Preparations